Summary

The compounding pharmacies market is gaining significant traction worldwide due to the growing need for customized medications tailored to individual patient requirements. These specialized pharmacies play a critical role in preparing personalized formulations when commercially available drugs fail to meet patient-specific needs, including allergy issues, unique dosage forms, or flavor preferences. As healthcare trends continue to shift toward personalized medicine, compounding pharmacies are emerging as a crucial component of the pharmaceutical supply chain.

Market Insights

According to Fairfield Market Research, the global compounding pharmacies market is projected to rise from US$ 10.9 billion in 2025 to US$ 17 billion by 2032, registering a CAGR of 6.56% during the forecast period. The increasing awareness about personalized treatment regimens, combined with advancements in compounding technology and drug formulation, is expected to elevate the market trajectory in the coming years.

Market Drivers

One of the primary drivers of the compounding pharmacies market is the rise in chronic conditions requiring individualized treatment plans. Patients with allergies to specific dyes or fillers, pediatric and geriatric patients needing specialized dosage forms, and individuals on specific dietary restrictions increasingly rely on compounded medications. Additionally, the global shortage of certain commercially available drugs has further fueled demand for compounded alternatives.

Hormone replacement therapy (HRT) is another significant contributor to market growth. With increasing awareness of hormonal imbalances and associated conditions such as menopause, erectile dysfunction, and infertility, the use of compounded hormone therapies has surged. These therapies allow patients to receive customized doses not typically available in mass-manufactured pharmaceuticals.

Business Opportunity

The market offers lucrative growth opportunities, especially in the development of innovative drug delivery systems. From flavored liquid medications for children to lollipops and topical formulations for dermatology and pain management, compounding pharmacies are expanding the boundaries of patient-friendly dosage forms. Partnerships with local manufacturers and strategic acquisitions are enabling key players to enhance their reach and product portfolios.

Moreover, the trend of integrating retail and compounding services within pharmacies is gaining momentum. This hybrid model boosts revenue potential while also offering convenience to patients. Market players are also capitalizing on the rising demand for bio-identical hormone replacement therapy (BHRT), particularly in regions with aging populations, to further expand their product offerings.

Region Analysis

The United States remains the dominant market for compounding pharmacies, attributed to its advanced healthcare infrastructure, rising prevalence of dermatological and chronic diseases, and high demand for customized medications. The increasing popularity of online compounding services and bio-identical hormone therapies is further contributing to market expansion in the region.

Germany is emerging as a key European market, driven by its rapidly aging population and growing demand for customized anti-aging and hormonal treatments. With projections indicating a significant increase in the elderly population by 2050, the need for tailored medications is expected to grow substantially.

Australia is also gaining recognition as a promising market, with growing interest in hormone-related therapies and an increasing number of patients seeking personalized treatment regimens. Compounding pharmacists are playing a vital role in supporting menopausal women through customized BHRT solutions.

Key Players

Prominent companies operating in the compounding pharmacies market include:

• Fagron

• Fresenius Kabi AG

• PharMEDium Services LLC

• Institutional Pharmacy Solutions

• Cantrell Drug Company

• Lorraine’s Pharmacy

• B.Braun Melsungen AG Company

These companies are focused on strategic collaborations, product innovation, and regional expansion to strengthen their market presence. Notable developments include new facility launches, mergers with raw material suppliers, and technological advancements in dosage form delivery.

Segmentation

By Product:

• Oral Medication

o Capsules

o Tablets

o Mixtures

o Lollipops

o Lozenges

• Topical Medications

o Gels

o Ointments

o Creams

o Lotions

o Mouthwashes

• Suppositories

By Application:

• Medication for Adults

• Medication for Children

• Medication for Geriatric

• Medication for Veterinary

By Therapeutic Area:

• Pain Management

• Hormone Replacement Therapy

By Region:

• North America

• Latin America

• Europe

• South Asia

• East Asia

• Oceania

• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Compounding Pharmacies Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Compounding Pharmacies Market Outlook, 2019-2032
3.1. Global Compounding Pharmacies Market Outlook, by Product, Value (US$ Bn), 2019-2032
3.1.1. Key Highlights
3.1.1.1. Oral Medication
3.1.1.1.1. Capsules
3.1.1.1.2. Tablets
3.1.1.1.3. Mixtures
3.1.1.1.4. Lollipops
3.1.1.1.5. Lozenges
3.1.1.2. Topical Medications
3.1.1.2.1. Gels
3.1.1.2.2. Ointments
3.1.1.2.3. Cream
3.1.1.2.4. Lotions
3.1.1.3. Mouthwashes
3.1.1.4. Suppositories
3.2. Global Compounding Pharmacies Market Outlook, by Application, Value (US$ Bn), 2019-2032
3.2.1. Key Highlights
3.2.1.1. Medication for Adults
3.2.1.2. Medication for Veterinary
3.2.1.3. Medication for Children
3.2.1.4. Medication for Geriatric
3.3. Global Compounding Pharmacies Market Outlook, by Therapeutic Area, Value (US$ Bn), 2019-2032
3.3.1. Key Highlights
3.3.1.1. Pain Management
3.3.1.2. Hormone Replacement Therapy
3.4. Global Compounding Pharmacies Market Outlook, by Region, Value (US$ Bn), 2019-2032
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Compounding Pharmacies Market Outlook, 2019-2032
4.1. North America Compounding Pharmacies Market Outlook, by Product, Value (US$ Bn), 2019-2032
4.1.1. Key Highlights
4.1.1.1. Oral Medication
4.1.1.1.1. Capsules
4.1.1.1.2. Tablets
4.1.1.1.3. Mixtures
4.1.1.1.4. Lollipops
4.1.1.1.5. Lozenges
4.1.1.2. Topical Medications
4.1.1.2.1. Gels
4.1.1.2.2. Ointments
4.1.1.2.3. Cream
4.1.1.2.4. Lotions
4.1.1.3. Mouthwashes
4.1.1.4. Suppositories
4.2. North America Compounding Pharmacies Market Outlook, by Application, Value (US$ Bn), 2019-2032
4.2.1. Key Highlights
4.2.1.1. Medication for Adults
4.2.1.2. Medication for Veterinary
4.2.1.3. Medication for Children
4.2.1.4. Medication for Geriatric
4.3. North America Compounding Pharmacies Market Outlook, by Therapeutic Area, Value (US$ Bn), 2019-2032
4.3.1. Key Highlights
4.3.1.1. Pain Management
4.3.1.2. Hormone Replacement Therapy
4.4. North America Compounding Pharmacies Market Outlook, by Country, Value (US$ Bn), 2019-2032
4.4.1. Key Highlights
4.4.1.1. U.S. Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
4.4.1.2. U.S. Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
4.4.1.3. U.S. Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
4.4.1.4. Canada Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
4.4.1.5. Canada Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
4.4.1.6. Canada Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Compounding Pharmacies Market Outlook, 2019-2032
5.1. Europe Compounding Pharmacies Market Outlook, by Product, Value (US$ Bn), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Oral Medication
5.1.1.1.1. Capsules
5.1.1.1.2. Tablets
5.1.1.1.3. Mixtures
5.1.1.1.4. Lollipops
5.1.1.1.5. Lozenges
5.1.1.2. Topical Medications
5.1.1.2.1. Gels
5.1.1.2.2. Ointments
5.1.1.2.3. Cream
5.1.1.2.4. Lotions
5.1.1.3. Mouthwashes
5.1.1.4. Suppositories
5.2. Europe Compounding Pharmacies Market Outlook, by Application, Value (US$ Bn), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Medication for Adults
5.2.1.2. Medication for Veterinary
5.2.1.3. Medication for Children
5.2.1.4. Medication for Geriatric
5.3. Europe Compounding Pharmacies Market Outlook, by Therapeutic Area, Value (US$ Bn), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Pain Management
5.3.1.2. Hormone Replacement Therapy
5.4. Europe Compounding Pharmacies Market Outlook, by Country, Value (US$ Bn), 2019-2032
5.4.1. Key Highlights
5.4.1.1. Germany Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
5.4.1.2. Germany Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
5.4.1.3. Germany Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
5.4.1.4. U.K. Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
5.4.1.5. U.K. Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
5.4.1.6. U.K. Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
5.4.1.7. France Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
5.4.1.8. France Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
5.4.1.9. France Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
5.4.1.10. Italy Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
5.4.1.11. Italy Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
5.4.1.12. Italy Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
5.4.1.13. Turkey Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
5.4.1.14. Turkey Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
5.4.1.15. Turkey Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
5.4.1.16. Russia Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
5.4.1.17. Russia Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
5.4.1.18. Russia Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
5.4.1.19. Rest of Europe Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
5.4.1.20. Rest of Europe Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
5.4.1.21. Rest of Europe Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Compounding Pharmacies Market Outlook, 2019-2032
6.1. Asia Pacific Compounding Pharmacies Market Outlook, by Product, Value (US$ Bn), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Oral Medication
6.1.1.1.1. Capsules
6.1.1.1.2. Tablets
6.1.1.1.3. Mixtures
6.1.1.1.4. Lollipops
6.1.1.1.5. Lozenges
6.1.1.2. Topical Medications
6.1.1.2.1. Gels
6.1.1.2.2. Ointments
6.1.1.2.3. Cream
6.1.1.2.4. Lotions
6.1.1.3. Mouthwashes
6.1.1.4. Suppositories
6.2. Asia Pacific Compounding Pharmacies Market Outlook, by Application, Value (US$ Bn), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Medication for Adults
6.2.1.2. Medication for Veterinary
6.2.1.3. Medication for Children
6.2.1.4. Medication for Geriatric
6.3. Asia Pacific Compounding Pharmacies Market Outlook, by Therapeutic Area, Value (US$ Bn), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Pain Management
6.3.1.2. Hormone Replacement Therapy
6.4. Asia Pacific Compounding Pharmacies Market Outlook, by Country, Value (US$ Bn), 2019-2032
6.4.1. Key Highlights
6.4.1.1. China Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
6.4.1.2. China Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
6.4.1.3. China Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
6.4.1.4. Japan Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
6.4.1.5. Japan Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
6.4.1.6. Japan Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
6.4.1.7. South Korea Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
6.4.1.8. South Korea Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
6.4.1.9. South Korea Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
6.4.1.10. India Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
6.4.1.11. India Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
6.4.1.12. India Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
6.4.1.13. Southeast Asia Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
6.4.1.14. Southeast Asia Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
6.4.1.15. Southeast Asia Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
6.4.1.16. Rest of Asia Pacific Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
6.4.1.17. Rest of Asia Pacific Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
6.4.1.18. Rest of Asia Pacific Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Compounding Pharmacies Market Outlook, 2019-2032
7.1. Latin America Compounding Pharmacies Market Outlook, by Product, Value (US$ Bn), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Oral Medication
7.1.1.1.1. Capsules
7.1.1.1.2. Tablets
7.1.1.1.3. Mixtures
7.1.1.1.4. Lollipops
7.1.1.1.5. Lozenges
7.1.1.2. Topical Medications
7.1.1.2.1. Gels
7.1.1.2.2. Ointments
7.1.1.2.3. Cream
7.1.1.2.4. Lotions
7.1.1.3. Mouthwashes
7.1.1.4. Suppositories
7.2. Latin America Compounding Pharmacies Market Outlook, by Application, Value (US$ Bn), 2019-2032
7.2.1. Key Highlights
7.2.1.1. Medication for Adults
7.2.1.2. Medication for Veterinary
7.2.1.3. Medication for Children
7.2.1.4. Medication for Geriatric
7.3. Latin America Compounding Pharmacies Market Outlook, by Therapeutic Area, Value (US$ Bn), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Pain Management
7.3.1.2. Hormone Replacement Therapy
7.4. Latin America Compounding Pharmacies Market Outlook, by Country, Value (US$ Bn), 2019-2032
7.4.1. Key Highlights
7.4.1.1. Brazil Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
7.4.1.2. Brazil Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
7.4.1.3. Brazil Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
7.4.1.4. Mexico Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
7.4.1.5. Mexico Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
7.4.1.6. Mexico Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
7.4.1.7. Argentina Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
7.4.1.8. Argentina Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
7.4.1.9. Argentina Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
7.4.1.10. Rest of Latin America Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
7.4.1.11. Rest of Latin America Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
7.4.1.12. Rest of Latin America Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Compounding Pharmacies Market Outlook, 2019-2032
8.1. Middle East & Africa Compounding Pharmacies Market Outlook, by Product, Value (US$ Bn), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Oral Medication
8.1.1.1.1. Capsules
8.1.1.1.2. Tablets
8.1.1.1.3. Mixtures
8.1.1.1.4. Lollipops
8.1.1.1.5. Lozenges
8.1.1.2. Topical Medications
8.1.1.2.1. Gels
8.1.1.2.2. Ointments
8.1.1.2.3. Cream
8.1.1.2.4. Lotions
8.1.1.3. Mouthwashes
8.1.1.4. Suppositories
8.2. Middle East & Africa Compounding Pharmacies Market Outlook, by Application, Value (US$ Bn), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Medication for Adults
8.2.1.2. Medication for Veterinary
8.2.1.3. Medication for Children
8.2.1.4. Medication for Geriatric
8.3. Middle East & Africa Compounding Pharmacies Market Outlook, by Therapeutic Area, Value (US$ Bn), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Pain Management
8.3.1.2. Hormone Replacement Therapy
8.4. Middle East & Africa Compounding Pharmacies Market Outlook, by Country, Value (US$ Bn), 2019-2032
8.4.1. Key Highlights
8.4.1.1. GCC Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
8.4.1.2. GCC Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
8.4.1.3. GCC Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
8.4.1.4. South Africa Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
8.4.1.5. South Africa Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
8.4.1.6. South Africa Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
8.4.1.7. Egypt Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
8.4.1.8. Egypt Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
8.4.1.9. Egypt Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
8.4.1.10. Nigeria Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
8.4.1.11. Nigeria Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
8.4.1.12. Nigeria Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
8.4.1.13. Rest of Middle East & Africa Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
8.4.1.14. Rest of Middle East & Africa Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
8.4.1.15. Rest of Middle East & Africa Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Product vs Therapeutic Area Heatmap
9.2. Manufacturer vs Therapeutic Area Heatmap
9.3. Company Market Share Analysis, 2025
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Fagron
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Fresenius Kabi AG
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. PharMEDium Services LLC
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Institutional Pharmacy Solutions
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Cantrell Drug Company
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Lorraine’s Pharmacy
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. B. Braun Melsungen AG Company
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development

10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations